Revive Therapeutics Ltd (RVVTF)
0.0132
0.00 (0.00%)
USD |
OTCM |
Jun 21, 16:00
Revive Therapeutics Shareholders Equity (Quarterly): 7.266M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 7.266M |
| December 31, 2023 | 7.185M |
| September 30, 2023 | 7.550M |
| June 30, 2023 | 8.038M |
| December 31, 2022 | 7.010M |
| September 30, 2022 | 8.072M |
| June 30, 2022 | 9.781M |
| March 31, 2022 | 12.10M |
| December 31, 2021 | 16.51M |
| September 30, 2021 | 18.97M |
| June 30, 2021 | 23.23M |
| March 31, 2021 | 24.83M |
| December 31, 2020 | 7.731M |
| September 30, 2020 | 6.998M |
| June 30, 2020 | 5.439M |
| March 31, 2020 | 4.256M |
| December 31, 2019 | 0.3713M |
| September 30, 2019 | 0.4982M |
| June 30, 2019 | 0.7319M |
| March 31, 2019 | 1.033M |
| December 31, 2018 | 0.2082M |
| September 30, 2018 | 0.4287M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.6194M |
| March 31, 2018 | 0.8898M |
| December 31, 2017 | 1.007M |
| September 30, 2017 | 0.9648M |
| June 30, 2017 | 1.242M |
| March 31, 2017 | 1.524M |
| December 31, 2016 | 1.041M |
| September 30, 2016 | 1.235M |
| June 30, 2016 | 0.4395M |
| March 31, 2016 | 0.1927M |
| December 31, 2015 | 0.5219M |
| September 30, 2015 | 1.112M |
| June 30, 2015 | 1.903M |
| March 31, 2015 | 2.299M |
| December 31, 2014 | 2.846M |
| September 30, 2014 | 0.9178M |
| June 30, 2014 | 1.186M |
| March 31, 2014 | 1.458M |
| December 31, 2013 | 1.631M |
| September 30, 2013 | 0.2777M |
| June 30, 2013 | 0.0827M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.3713M
Minimum
Dec 2019
24.83M
Maximum
Mar 2021
9.293M
Average
7.550M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 4.324M |
| Lexaria Bioscience Corp | 6.521M |
| Xenon Pharmaceuticals Inc | 887.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.727M |
| Total Liabilities (Quarterly) | 2.461M |